Crispr Therapeutics Ag · NASDAQ:CRSP
Behbahani Ali sold 13,679 Crispr Therapeutics Ag shares (Form 4)
Traded Sep 17, 2026 · Filed Sep 21, 2026
On Sep 17, 2026, Behbahani Ali (Director) sold 13,679 Crispr Therapeutics Ag shares at US$57.09 for US$781K, leaving 16,637 shares. Filed Sep 21, 2026 (Form 4).
- Sold
- 13,679 shares
- Price
- US$57.09
- Value
- US$781K
- Holding after
- 16,637 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 17, 2026 | Common Shares | Option exercise | 30,000 | US$14.00 | 30,316 | Direct |
| Sep 17, 2026 | Common Shares | Sale | 13,679 | US$57.09 | 16,637 | Direct |
Source
Related
- Crispr Therapeutics Ag
- Behbahani Ali
- Crispr Therapeutics Ag shareholders
- Form 4 · Behbahani Ali · Sep 21, 2026
- Form 4 · George Simeon · Oct 16, 2026
- Form 4 · Kasinger James R. · Oct 15, 2026
- Form 4 · Kulkarni Samarth · Oct 15, 2026
- Form 4 · Kasinger James R. · Oct 8, 2026
- Form 4 · Kasinger James R. · Sep 24, 2026